High-dose chemotherapy and transplantation of autologous CD34+ selected stem cells for progressive systemic sclerosis adjusted to cardiac and lung manifestation: An open-label, non-inferiority phase 2 trial
2026 · Joint Bone Spine · 0 citations
https://doi.org/10.1016/j.jbspin.2026.106032